Wenbing Liu

6PUBLICATIONS
31CO-AUTHORS
HaematologyRespiratory diseasesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 07, 2026
Author Correction: Proteasome-guided haem signalling axis contributes to T cell exhaustion.

|Mar 19, 2026
Proteasome-guided haem signalling axis contributes to T cell exhaustion.

Yingxi Xu, Yangtao Shangguan, Yu-Ming Chuang

|Sep 05, 2025
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Jun 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Nov 01, 2024
The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patients.

Shaowei Qiu, Yihan Mei, Runxia Gu

|Sep 16, 2024
Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia.

Yu Liu, Wenbing Liu, Anli Lai

Pageof 1

Frequent Collaborators

6 joint publications

Jianxiang Wang

4 joint publications

Shaowei Qiu

4 joint publications

Hui Wei

3 joint publications

Runxia Gu